Human Mesothelin Propeptide/MPF Antibody
R&D Systems, part of Bio-Techne | Catalog # AF3448
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Mesothelin Propeptide/MPF isoform 1
Arg35-Leu289
Accession # Q13421
Arg35-Leu289
Accession # Q13421
Specificity
Detects human Mesothelin Propeptide/MPF in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross‑reactivity with mature recombinant human Mesothelin is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Human Mesothelin Propeptide/MPF Antibody
Application
Recommended Usage
Western Blot
0.1 µg/mL
Sample: Recombinant Human Mesothelin Propeptide/MPF
Sample: Recombinant Human Mesothelin Propeptide/MPF
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Mesothelin
Alternate Names
CAK1, MPF, MSLN, SMR
Gene Symbol
MSLN
UniProt
Additional Mesothelin Products
Product Documents for Human Mesothelin Propeptide/MPF Antibody
Product Specific Notices for Human Mesothelin Propeptide/MPF Antibody
For research use only
Loading...
Loading...
Loading...
Loading...